Sensorion (XPAR:ALSEN) Other Gross PPE : €2.34 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Sensorion Other Gross PPE?

Sensorion's Other Gross PPE for the quarter that ended in Dec. 2023 was €2.34 Mil.

Sensorion's quarterly Other Gross PPE increased from Dec. 2022 (€1.06 Mil) to Jun. 2023 (€2.30 Mil) and increased from Jun. 2023 (€2.30 Mil) to Dec. 2023 (€2.34 Mil).

Sensorion's annual Other Gross PPE increased from Dec. 2021 (€1.03 Mil) to Dec. 2022 (€1.06 Mil) and increased from Dec. 2022 (€1.06 Mil) to Dec. 2023 (€2.34 Mil).

Sensorion Other Gross PPE Historical Data

The historical data trend for Sensorion's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensorion Other Gross PPE Chart

Sensorion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

0.61

0.65

1.03

1.06

2.34

Sensorion Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															1.03	1.36	1.06	2.30	2.34

Sensorion Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Sensorion (XPAR:ALSEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

RFM:Germany

Address

375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080

Website

https://www.sensorion.com/en

Sensorion SA is a France-based clinical-stage biotech company dedicated to the development of therapies to restore, treat and prevent hearing loss. The company's product is in phase 2 clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies.

Sensorion (XPAR:ALSEN) Headlines

No Headlines